Market Overview:
The global pharmaceutical grade dextran market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for dextran products in various applications, such as solutions for injection and infusion, and dextran derivatives. In addition, the growing demand for pharmaceutical grade dextran products in emerging markets is also contributing to the growth of this market. On the basis of type, the global pharmaceutical grade dextran market can be segmented into Dextran 20, Dextran 40, Dextran 60, Dextran 70 and other types. Among these types, DeXTAN 40 held a major share of the global pharmaceutical grade deXTAN market in 2017 and is expected to continue its dominance duringthe forecast period as well.
Product Definition:
A pharmaceutical grade dextran is a purified form of dextran that has been manufactured to meet the requirements of the United States Pharmacopeia (USP). It is used as an excipient in pharmaceutical products.
Dextran 20:
Dextran 20 is a type of synthetic blood sugar. It is used as a stabilizing agent in pharmaceuticals and medical food products. Dextran 20 has the ability to bind with water and enhance the stability of other ingredients, which makes it suitable for use in intravenous solutions, oral dosage forms, injections (intravenous or intramuscular), topical formulations, ophthalmic solutions and ointments among others.
Dextran 40:
Dextran 40 is a type of synthetic heparin, which is used as an anticoagulant drug in the medical industry. It has been approved by the U.S Food and Drug Administration (FDA) for use in humans as a safe substitute for heparin sodium in various medical applications including surgery.
Application Insights:
Solutions for injection and infusion was the largest application segment in terms of revenue share in 2017. The segment is expected to witness significant growth on account of increasing hospital admissions and surgeries globally. According to WHO, an average global citizen will undergo more than 6 surgeries during their lifetime. Increasing healthcare spending as a result of growing aging population coupled with rising burden of chronic diseases are anticipated to boost demand for dextran-based solutions over the forecast period.
Dextran derivatives are used as solvents, wetting agents, emulsifiers and foaming agents across various industries such as food & beverage processing, personal care & cosmetics manufacturing among others which is likely to propel industry expansion over the coming years. Other major applications include use in radiographic imaging materials such as X-ray films and plates among others which can be attributed towards high product consumption globally due to its low molecular weight properties that make it ideal for use in radiographic imaging materials compared to other products available in the market today.
Regional Analysis:
Asia Pacific pharmaceutical grade dextran market led the global industry and accounted for over 40% of the total revenue share in 2016. This can be attributed to high product demand from countries such as Japan, China, India, South Korea & Australia. The region is expected to witness significant growth owing to increasing healthcare spending by governments and rising awareness about advanced medicines among people.
The Asia Pacific pharmaceutical grade dextran market is anticipated to grow at a CAGR of XX% during the forecast period due to increasing product use in surgeries and IVF procedures along with growing medical tourism in emerging economies such as China & India. In addition, factors such as favorable government initiatives for improving healthcare infrastructure are likely to drive regional demand during the forecast period.
Growth Factors:
- Increasing demand for dextran in the pharmaceutical and biotechnology industries for various applications such as drug delivery, cell culture, and protein purification.
- Growing research on dextran's potential therapeutic applications in cancer treatment, diabetes management, and other diseases is expected to boost the market growth.
- Rising number of clinical trials being conducted on dextran is anticipated to propel the market growth over the forecast period.
- Increasing investment by key players in R&D activities for developing new products is likely to provide impetus to the market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Grade Dextran Market Research Report
By Type
Dextran 20, Dextran 40, Dextran 60, Dextran 70, Other
By Application
Solutions for Injection and Infusion, Dextran Derivative, Other
By Companies
Pharmacosmos, PK Chemicals, Meito Sangyo, Polydex Pharm, Jinyang Biological Pharmaceutical, Pharmacosmos
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
126
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Grade Dextran Market Report Segments:
The global Pharmaceutical Grade Dextran market is segmented on the basis of:
Types
Dextran 20, Dextran 40, Dextran 60, Dextran 70, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Solutions for Injection and Infusion, Dextran Derivative, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pharmacosmos
- PK Chemicals
- Meito Sangyo
- Polydex Pharm
- Jinyang Biological Pharmaceutical
- Pharmacosmos
Highlights of The Pharmaceutical Grade Dextran Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dextran 20
- Dextran 40
- Dextran 60
- Dextran 70
- Other
- By Application:
- Solutions for Injection and Infusion
- Dextran Derivative
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Grade Dextran Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dextran is a type of sugar molecule that is used as a pharmaceutical agent. It is often used to treat blood clots, and it can also be used in the treatment of other medical conditions.
Some of the key players operating in the pharmaceutical grade dextran market are Pharmacosmos, PK Chemicals, Meito Sangyo, Polydex Pharm, Jinyang Biological Pharmaceutical, Pharmacosmos.
The pharmaceutical grade dextran market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Grade Dextran Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Grade Dextran Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Grade Dextran Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Grade Dextran Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Grade Dextran Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Grade Dextran Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Grade Dextran Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Grade Dextran Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Grade Dextran Market Size Forecast by Type
5.2.1 Dextran 20
5.2.2 Dextran 40
5.2.3 Dextran 60
5.2.4 Dextran 70
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Grade Dextran Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Grade Dextran Market Size Forecast by Applications
6.2.1 Solutions for Injection and Infusion
6.2.2 Dextran Derivative
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Grade Dextran Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Grade Dextran Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Grade Dextran Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Grade Dextran Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Grade Dextran Market Size Forecast by Type
9.6.1 Dextran 20
9.6.2 Dextran 40
9.6.3 Dextran 60
9.6.4 Dextran 70
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Grade Dextran Market Size Forecast by Applications
9.10.1 Solutions for Injection and Infusion
9.10.2 Dextran Derivative
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Grade Dextran Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Grade Dextran Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Grade Dextran Market Size Forecast by Type
10.6.1 Dextran 20
10.6.2 Dextran 40
10.6.3 Dextran 60
10.6.4 Dextran 70
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Grade Dextran Market Size Forecast by Applications
10.10.1 Solutions for Injection and Infusion
10.10.2 Dextran Derivative
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Grade Dextran Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Grade Dextran Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Grade Dextran Market Size Forecast by Type
11.6.1 Dextran 20
11.6.2 Dextran 40
11.6.3 Dextran 60
11.6.4 Dextran 70
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Grade Dextran Market Size Forecast by Applications
11.10.1 Solutions for Injection and Infusion
11.10.2 Dextran Derivative
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Grade Dextran Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Grade Dextran Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Grade Dextran Market Size Forecast by Type
12.6.1 Dextran 20
12.6.2 Dextran 40
12.6.3 Dextran 60
12.6.4 Dextran 70
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Grade Dextran Market Size Forecast by Applications
12.10.1 Solutions for Injection and Infusion
12.10.2 Dextran Derivative
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Grade Dextran Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Grade Dextran Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Grade Dextran Market Size Forecast by Type
13.6.1 Dextran 20
13.6.2 Dextran 40
13.6.3 Dextran 60
13.6.4 Dextran 70
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Grade Dextran Market Size Forecast by Applications
13.10.1 Solutions for Injection and Infusion
13.10.2 Dextran Derivative
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Grade Dextran Market: Competitive Dashboard
14.2 Global Pharmaceutical Grade Dextran Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pharmacosmos
14.3.2 PK Chemicals
14.3.3 Meito Sangyo
14.3.4 Polydex Pharm
14.3.5 Jinyang Biological Pharmaceutical
14.3.6 Pharmacosmos
